---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-005476"
form_type: "8-K"
ticker: "PBSV"
cik: "0001304161"
company_name: "Pharma-Bio Serv, Inc."
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T00:04:28.580560+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve extension of long-term incentive plan to 2034; re-elect two directors

## Summary
- Stockholders approved extending the 2014 Long-Term Incentive Plan term to March 31, 2034.
- Re-elected Kirk Michel (12.65M votes for) and Dov Perlysky (7.55M votes for) as Class II directors until 2027.
- Crowe PR PSC ratified as independent auditor for fiscal year ending Oct 31, 2024 (14.36M for, 1.5K against).

## SEC filing metadata
- accession: 0001654954-24-005476
- form_type: 8-K
- ticker: PBSV
- cik: 0001304161
- company_name: Pharma-Bio Serv, Inc.
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1304161/000165495424005476/0001654954-24-005476-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1304161/000165495424005476/pbsv_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-005476
- JSON: https://secwatch.observer/filing/0001654954-24-005476.json
- Plain text: https://secwatch.observer/filing/0001654954-24-005476.txt

## Key facts
- Shareholder Votes
  Pharma-Bio Serv, Inc. shareholders approved Approval of the Plan Amendment.
  - Proposal: equity plan
  - Outcome: passed
  source text: The approval of the Plan Amendment received the following votes: Votes For Votes Against Abstain 7,523,008 5,127,032 3,854,521 There were 1,714,854 broker non-votes on this proposal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1304161/000165495424005476/0001654954-24-005476-index.htm
- Shareholder Votes
  Pharma-Bio Serv, Inc. shareholders approved Election of Class II Directors.
  - Proposal: director election
  - Outcome: passed
  source text: Kirk Michel and Dov Perlysky received the following votes: Nominee Votes For Votes Withheld Kirk Michel 12,647,540 3,857,021 Dov Perlysky 7,546,374 8,958,187 There were 1,714,854 broker non-votes on this proposal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1304161/000165495424005476/0001654954-24-005476-index.htm
- Shareholder Votes
  Pharma-Bio Serv, Inc. shareholders approved Ratification of Crowe PR PSC as independent certified public accountants at the 2024-10-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2024-10-31
  source text: The ratification of the selection of Crowe PR PSC as the Company's independent certified public accountants for the fiscal year ending October 31, 2024 received the following votes: Votes For Votes Against Abstain 14,364,694 1,500 3,853,221 There were no broker non-votes on this proposal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1304161/000165495424005476/0001654954-24-005476-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.